StockNews.com Begins Coverage on Lipocine (NASDAQ:LPCN)
Investment analysts at StockNews.com assumed coverage on shares of Lipocine (NASDAQ:LPCN – Get Free Report) in a report released on Monday. The firm set a “hold” rating on the specialty pharmaceutical company’s stock. Lipocine Stock Performance LPCN stock opened at $3.41 on Monday. The business has a 50-day simple moving average of $4.72 and a […]
![StockNews.com Begins Coverage on Lipocine (NASDAQ:LPCN)](https://www.americanbankingnews.com/wp-content/timthumb/timthumb.php?src=https://www.marketbeat.com/logos/lipocine-inc-logo-1200x675.png?v=20230110211227&w=240&h=240&zc=2)